Loading companies…
Loading companies…
United States · Biotech · Healthtech
Develops novel small-molecule therapies for neurodegenerative and inflammatory diseases
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $12M | Double Point Ventures — Role not disclosed |